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Recent outbreaks of enterovirus in Southeast Asia 
emphasize difficulties in diagnosis of this infection. To ad-
dress this issue, we report 5 (4.7%) children infected with 
enterovirus 75 among 106 children with acute encephalitis 
syndrome during 2005–2007 in southern India. Throat swab 
specimens may be useful for diagnosis of enterovirus 75 
infection. 
Sequences of enterovirus 75 (EV75) were first identi-fied in cerebrospinal fluid (CSF), stool samples, and 
throat samples obtained during 1974–2000 in Ethiopia, 
Oman, Bangladesh, and the United States; the new entero-
virus serotype was proposed in 2004 (1). Manifestations 
include upper respiratory tract infections and acute flaccid 
paralysis. In 2005–2006, EV75 was associated with aseptic 
meningitis in Spain (2,3). Enteroviruses have long been as-
sociated with encephalitis, but recent outbreaks of EV71 in 
Southeast Asia have highlighted the diagnostic difficulties 
that may be encountered (4–6). We report EV75 associated 
with encephalitis in India.
The Study
We prospectively studied children <16 years of age 
who came to the Pediatric Department at the Vijayanagar 
Institute of Medical Sciences, Bellary, Karnataka, south-
ern India, with acute encephalitis syndrome during October 
2005–December 2007. Children with acute fever and symp-
toms with an onset <14 days before coming to the hospital, 
a neurologic illness, and >1 of the following signs (change 
in mental status including confusion, disorientation, coma, 
or inability to talk; new onset of seizures excluding simple 
febrile seizures; photophobia, headache, or meningitis) 
were recruited into the study. Children with laboratory-
confirmed Plasmodium falciparum parasitemia or a history 
of neurologic conditions and those whose parents removed 
them from the hospital were excluded. The study protocol 
was reviewed and approved by the ethics committees of 
Vijayanagar Institute of Medical Sciences and the Univer-
sity of Liverpool, UK. Informed consent was obtained from 
parents or guardians.
For each child, a completed medical history was ob-
tained and a detailed physical examination was performed. 
Samples were obtained for routine diagnostics. Rectal and 
throat samples were also collected after December 2005. 
Swabs were placed in sterile vials containing viral culture 
media (Dulbecco’s modified Eagle’s medium). All samples 
were frozen at –20°C, stored at –70°C, and transferred to 
diagnostic laboratories.
To detect enteroviruses, including EV75, in throat swab 
extracts, RNA was extracted by using the Chemagic Viral 
DNA/RNA kit (Chemagen AG, Baesweiler, Germany) and 
a Kingfisher mL Magnetic Extractor (Thermo Fisher Sci-
entific Inc., Waltham, MA, USA). Pan-enterovirus reverse 
transcription–PCR (RT-PCR) was then performed by using 
primers specific for the 5′ untranslated region (5′-ATT GTC 
ACC ATA AGC AGC CA-3′ and 5′-CCT CCG GCC CCT 
GAA TGC GGC TAA T-3′); these primers produced a 154-
bp product (7). Enteroviruses identified by pan-enterovirus 
RT-PCR were typed by nucleotide sequencing of the viral 
protein 1 (VP1) region (8,9).
To further type enteroviruses, phylogenetic analysis 
was performed on all nucleotide sequences (from this study 
and others obtained from GenBank) by using MEGA4 soft-
ware (10) (www.megasoftware.net). The remaining swab 
transport medium was filtered, and 100 μL of filtrate was 
aliquoted onto each of 3 tissue culture plates containing 
rhabdomyosarcoma, Vero, and 293T cell lines for virus 
isolation. Cell lines were chosen to facilitate culturing of 
a range of viruses that may have been responsible for the 
clinical spectrum of illness seen.
Because CSF volume for virus isolation was limited to 
a 100-μL sample, this sample was placed on rhabdomyo-
sarcoma cells for isolation and identification of enterovi-
ruses. All CSF and serum samples were tested by using an 
immunoglobulin M capture ELISA to detect antibodies to 
Japanese encephalitis virus (JEV) and dengue virus, which 
circulate in the study region (11). If a sufficient amount of 
CSF remained, RNA was extracted by using the Viral RNA 
Mini Extraction Kit (QIAGEN, Hilden, Germany) accord-
ing to the manufacturer’s instructions for pan-enterovirus 
RT-PCR, as described above and for a JEV RT-PCR (7,12). 
Plasma samples were also tested for chikungunya virus by 
using RT-PCR (13).
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